Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline for Late-Life Depression and CAD Risk
NCT01625845Phase 2Completed
- Sponsor
- Indiana University
- Start
- Jun 2012
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pentoxifylline in major depressive disorder (MDD), sponsored by Indiana University. Started Jun 2012; status: completed.
02
Drugs
pentoxifylline
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT01625845.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01625845.